These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31424086)

  • 1. Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.
    van der Kroef M; van den Hoogen LL; Mertens JS; Blokland SLM; Haskett S; Devaprasad A; Carvalheiro T; Chouri E; Vazirpanah N; Cossu M; Wichers CGK; Silva-Cardoso SC; Affandi AJ; Bekker CPJ; Lopes AP; Hillen MR; Bonte-Mineur F; Kok MR; Beretta L; Rossato M; Mingueneau M; van Roon JAG; Radstake TRDJ
    Eur J Immunol; 2020 Jan; 50(1):119-129. PubMed ID: 31424086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
    Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
    Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.
    Andraos R; Ahmad A; Eriksson P; Dahlström Ö; Wirestam L; Dahle C; Hesselstrand R; Bengtsson AA; Jönsen A; Andréasson K; Sjöwall C
    Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
    Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
    Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Phenotyping of CD11c
    Rincon-Arevalo H; Wiedemann A; Stefanski AL; Lettau M; Szelinski F; Fuchs S; Frei AP; Steinberg M; Kam-Thong T; Hatje K; Keller B; Warnatz K; Radbruch A; Lino AC; Schrezenmeier E; Dörner T
    Front Immunol; 2021; 12():635615. PubMed ID: 33777025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative single-cell multiplex immunophenotyping of therapy-naive patients with rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus shed light on disease-specific composition of the peripheral immune system.
    Balog JÁ; Zvara Á; Bukovinszki V; Puskás LG; Balog A; Szebeni GJ
    Front Immunol; 2024; 15():1376933. PubMed ID: 38726007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.
    Hebbar M; Jeannin P; Magistrelli G; Hatron PY; Hachulla E; Devulder B; Bonnefoy JY; Delneste Y
    Clin Exp Immunol; 2004 May; 136(2):388-92. PubMed ID: 15086406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.
    McCormick N; Marra CA; Sadatsafavi M; Kopec JA; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):142-154. PubMed ID: 29648677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
    Szabó K; Papp G; Szántó A; Tarr T; Zeher M
    Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosis.
    Maslyanskiy A; Lazareva N; Olinek P; Schierack P; Hentschel C; Cuccato J; Bogdanos DP; Lapin SV; Roggenbuck D
    J Immunol Res; 2014; 2014():516593. PubMed ID: 24883333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
    Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autoimmune diseases.
    Condemi JJ
    JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
    Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
    Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver abnormalities in connective tissue diseases.
    De Santis M; Crotti C; Selmi C
    Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):543-51. PubMed ID: 24090941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of celiac disease in systemic lupus erythematosus, sjogren syndrome and systemic sclerosis: A systematic review and meta-analysis.
    Beas R; Altamirano-Farfan E; Izquierdo-Veraza D; Norwood DA; Riva-Moscoso A; Godoy A; Montalvan-Sanchez EE; Ramirez M; Guifarro DA; Kitchin E; Fischer M; Kurada S
    Dig Liver Dis; 2024 Sep; 56(9):1475-1482. PubMed ID: 38584032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nervous system involvement in systemic lupus erythematosus, Sjögren syndrome and scleroderma.
    Hietaharju A; Jäntti V; Korpela M; Frey H
    Acta Neurol Scand; 1993 Oct; 88(4):299-308. PubMed ID: 8256578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification of Patients With Sjögren's Syndrome and Patients With Systemic Lupus Erythematosus According to Two Shared Immune Cell Signatures, With Potential Therapeutic Implications.
    Martin-Gutierrez L; Peng J; Thompson NL; Robinson GA; Naja M; Peckham H; Wu W; J'bari H; Ahwireng N; Waddington KE; Bradford CM; Varnier G; Gandhi A; Radmore R; Gupta V; Isenberg DA; Jury EC; Ciurtin C
    Arthritis Rheumatol; 2021 Sep; 73(9):1626-1637. PubMed ID: 33645922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjogren's syndrome is associated with and not secondary to systemic sclerosis.
    Salliot C; Mouthon L; Ardizzone M; Sibilia J; Guillevin L; Gottenberg JE; Mariette X
    Rheumatology (Oxford); 2007 Feb; 46(2):321-6. PubMed ID: 16877466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.